Cyclooxygenase-2-specific inhibitors: Mechanism of action;Cyclooxygenase-2-spezifische inhibitoren: Grundlegende aspekte des wirkmechanismus

Aktuelle Rheumatologie

Volumn 24, Issue 3, 1999, Pages 63-68

  Fisch, Ulrich W ^a,d   Brauer, H G ^b   Mahr, G ^c   Vergin, H ^a  

^a Searle GmbH   (Germany)

^b DocuMed GmbH   (Germany)

^c mpc   (Germany)

^d Heumann Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; ISOMERASE; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE; THROMBOXANE SYNTHASE;

DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HUMAN; PAIN; REVIEW;

EID: 0032710521     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043550     Document Type: Review

References (46)

1. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX-2) reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97: 2672-2679
2. Bakhle YS, Botting RM. Cyclooxygenase-2 and its regulation in inflammation. Mediatros Inflamm 1996; 5: 305-323
3. Beswick PJ, Campbell IB, Naylor A, Inventors; Glaxo Group Ltd. Assignee. Potent and selective cyclooxygenase-2 inhibitors - Patient publication No.: W09631509. Exp Opin Ther Patents 1997; 3: 275-276
4. Browner MF. The structure of human cyclooxygenase-2 and selective inhibitors. In: Vane J, Botting J (eds.). Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential. Proceedings of a conference held on March 20-21, 1997 in Cannes, France. London: Kluwer Academic Publishers, Dordrecht and William Harvey Press 1998: 19-26
5. Brune K, Glatt M, Graf P. Mechanism of action of anti-inflammatory drugs. Gen Pharmacol 1976; 7: 27-33
6. Brune K, Hinz B. Zum aktuellen Stand der Zyklooxygenase-Forschung. Dtsch Ärztebl 1998; 95: A343-A346
7. Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 1994; 91: 11202-11206
8. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994; 93: 1095-1101
9. Crofford LJ. Expression and regulation of COX-2 in synovial tissues of arthritic patients. In: Vane J, Botting J, Botting R (eds.). Anti-inflammatory drugs. COX-2 enzyme inhibitors. Proceedings of a conference held on October 10-11,1995 at Regent's College, London. London: Kluwer Academic Publishers, Dordrecht, and William Harvey Press 1998: 133-143
10. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997; 24 (49): 15-19
11. DeWitt DL, Bhattacharyya D, Lecomte M, Smith WL. The differential susceptibility of prostaglandin endoperoxide H synthases-1 and -2 to nonsteroidal anti-inflammatory drugs: aspirin derivatives as selective inhibitors. Med Chem Res 1995; 5: 325-343
12. Emery P. Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol 1996; 25 (102): 23-28
13. Ford-Hutchinson AW. New highly selective COX-2 inhibitors: In: Vane J, Botting J (eds.). Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential. Proceedings of a conference held on March 20-21, 1997 in Cannes, France. London: Kluwer Academic Publishers, Dordrecht, and William Harvey Press 1998: 117-125
14. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990: 265: 16737-16740
15. Garavito RM. The three-dimensional structure of cyclooxygenases. In: Vane J, Botting J, Botting R (eds.). Anti-inflammatory drugs: COX-2 enzyme inhibitors. Proceedings of a conference held on October 10-11, 1995 at Regent's College, London. London: Kluwer Academic Publishers, Dordrecht, and Williams Harvey Press 1996: 29-43
16. Gierse JK, McDonald JJ, Hauser SD; Rangwala SH, Koboldt CM, Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996: 271; 15810-15814
17. Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996; 16: 181-206
18. Isakson P, Zweifel B, Masferrer J, Koboldt C, Seibert K, Hubbard R, Geis S, Needleman P. Specific COX-2 inhibitors: from bench to bedside. In: Vane J, Botting J (eds.). Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential. Proceedings of a conference held on March 20-21, 1997 in Cannes, France. London: Kluwer Academic Publishers, Dordrecht, and Williams Harvey Press 1998: 127-133
19. Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P. Cyclooxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 1997; 53: 563-582
20. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, O'Neil G. Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996: 111: 445-454
21. Kulmacz RJ, Pendleton RB, Lands WE. Interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase. Interpretation of reaction kinetics. J Biol Chem 1994; 269: 5527-5536
22. Kurumball RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents (published erratum appears in Nature 1997; 385: 555). Nature 1996; 384: 644-648
23. Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding. Lancet 1991; 337: 85-89
24. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 1996; 3: 927-933
25. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucokorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992; 89: 3917-3921
26. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232
27. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, Herschman HR. In vivo glucokorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol ExpTher 1994; 270: 1340-1344
28. Masferrer JL, Isakson PC, Seibert K. Cyclooxygenase-2 inhibitors. A new class of antiinflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 1996; 25: 363-372
29. Needleman P, Isakson PC. The discovery and function of COX-2. APLAR J Rheumatol 1997; 1: 129-131
30. Needleman P, Iskason PC. Selective inhibition of cyclooxygenase 2. Sci Med 1998; 5: 26-35
31. Neugebauer V, Schaible G, He X, Lücke T, Gründling P, Schmidt RF. Electrophysiological evidence for a spinal antinociceptive action of dipyrone. Agents Actions 1994; 41: 62-70
32. O'Neil GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993; 330: 156-160
33. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3 (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635,celecoxib). J Med Chem 1997; 40: 1347-1365
34. 2 synthase-1. Nature 1994; 367: 243-249
35. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996; 184: 883-891
36. Ristimäki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996; 318: 325-331
37. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer JL, Perkins W, Lee L, Iskason PC. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-12017
38. Seibert K, Masferrer JL, Zhang Y, Gregory SA, Olson G, Hauser SD, Leahy K, Perkins W, Isakson PC. Mediation of inflammation by cyclooxygenase-2. Agents Actions 1995 (suppl. 46): 41-50
39. Shimada SG, Otterness IG, Stitt JT. A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 1994; 41: 188-192
40. Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971; 231: 235-239
41. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthase-1 and -2. Adv Immunol 1996: 62: 167-215
42. Tanaka K, Kawasaki H, Kurata K, Aikawa Y, Tsukamoto Y, Inaba T. T-614, a novel antirheumatic drug inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts. Jpn J Pharmacol 1995; 67: 305-314
43. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 1971; 231: 232-235
44. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs: an overview. In: Vane J, Botting J (eds.). Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential. Proceedings of a conference held on March 20-21, 1997 in Cannes, France. London: Kluwer Academic Publishers, Dordrecht, and Williams Harvey Press 1998: 1-17
45. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 2692-2696
46. Xie WL, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 1992; 25: 249-265